Skip to main content
SpringerLink
Log in

Atlas and Anatomy of PET/CT

  • Chapter
  • First Online:
Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT

  • 1157 Accesses

Abstract

PET/CT is a combined system of positron emission tomography (PET) and computed tomography (CT) scanners. PET can detect abnormal metabolic activity in organs or lesions even before they show morphological changes and CT enables precise localization, so co-registration of functional and anatomic information is achieved in the same study, obtained on the same scanner [1]. This technology, available now for at least 10 years, has allowed great advances especially in the field of oncology, and every day it opens more fields to explore in this and other multiple pathologies [2]. Nowadays there is also the possibility of carrying out total body PET studies, which encompasses the entire body within the field of view of the scanner, allowing imaging of all the tissues and organs simultaneously. The increase in geometric coverage of total body PET and multiple adjusted parameters make the whole-body image a very sensitive study with major implications for medical imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kapoor V, McCook BM, Torok F. An introduction to PET-CT imaging. RadioGraphics. 2004;24:523–43.

    Article  PubMed  Google Scholar 

  2. Walrand S, Hesse M, Jamar F. Update on novel trends in PET/CT technology and its clinical applications. Br J Radiol. 2016;89:20160534.

    Google Scholar 

  3. Salaun PY, Abgral R, Mallard O, Querellou-Lefranc S, Quere G, Wartski M, et al. Good clinical practice recommendations for the use of PET/CT in oncology. Eur J Nucl Med Mol Imaging. 2020;47:28–50.

    Article  PubMed  Google Scholar 

  4. Voltin CA, Mettler J, Grosse J, Dietlein M, Baues C, Schmitz C, et al. FDG-PET imaging for Hodgkin and diffuse large B-cell lymphoma-an updated overview. Cancers. 2020;12(3):601.

    Article  CAS  PubMed Central  Google Scholar 

  5. Hadique S, Jain P, Hadi Y, et al. Utility of FDG PET / CT for assessment of lung nodules identified during low dose computed tomography screening. BMC Med Imaging. 2020;20:69.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Matteucci F, Paganelli G, Martinelli G, Cerchione C. PET/CT in multiple myeloma: beyond FDG. Front Oncol. 2021;25(10):622501.

    Article  Google Scholar 

  7. Nikolova PN, Hadzhiyska VH, Mladenov KB, Ilcheva MG, Veneva S, Grudeva VV, et al. The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin. Neoplasma. 2021;68(1):180–9.

    Article  PubMed  Google Scholar 

  8. El-Shourbagy KH, Mashaly EM, Khodair SA, et al. PET / CT in restaging, prognosis, and recurrence in patients with malignant melanoma. Egypt J Radiol Nucl Med. 2020;51:167.

    Article  Google Scholar 

  9. Grosse J, Hellwig D. PET / CT und PET / MRT bei Tumoren des Kopf-Hals-Bereichs [PET / CT and PET / MRI in head and neck cancer]. Laryngorhinootologie. 2020;99(1):12–21.

    Article  PubMed  Google Scholar 

  10. Kaseda K. Recent and current advances in FDG-PET imaging within the field of clinical oncology in NSCLC: a review of the literature. Diagnostics. 2020;10(8):561.

    Article  CAS  PubMed Central  Google Scholar 

  11. Adam JA, Loft A, Chargari C, et al. EANM / SNMMI practice guideline for [18F] FDG PET / CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0. Eur J Nucl Med Mol Imaging. 2021;48:1188–99.

    Article  PubMed  Google Scholar 

  12. Jelercic S, Rajer M. The role of PET-CT in radiotherapy planning of solid tumors. Radiol Oncol. 2015;49(1):1–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Maffione AM, Rubello D, Caroli P, Colletti P, Matteucci F. Is it time to introduce PET / CT in colon cancer guidelines? Clin Nucl Med. 2020;45(7):525–30.

    Article  PubMed  Google Scholar 

  14. Bruzzi JF, Munden RF, Truong MT, Marom EM, Sabloff BS, Gladish GW, et al. PET / CT of esophageal cancer: its role in clinical management. RadioGraphics. 2007;27(6):1635–52.

    Article  PubMed  Google Scholar 

  15. Lan BY, Kwee SA, Wong LL. Positron emission tomography in hepatobiliary and pancreatic malignancies: a review. Am J Surg. 2012;204(2):232–41.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Dascălu RI, Nicolae P, Bolocan A, Ion D, Andronic O. The role of PET-CT in gastric cancer - a narrative review. Sudan J Med Sci (SJMS). 2020;15(3):332–44.

    Google Scholar 

  17. Giammarile F, Castellucci P, Dierckx R, et al. Non-FDG PET / CT in diagnostic oncology: a pictorial review. Eur J Hybrid Imaging. 2019;3:20.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hasan O, Nguyen M, Son H, Puri S. Role of FDG PET/CT in detecting unsuspected brain metastases during routine staging work up in oncology practice and its impact on patient management. J Nucl Med. 2014;55(supplement 1):1303.

    Google Scholar 

  19. Ghosh PS, Tekautz T, Mitra S. Pearls & Oy-sters: bifocal germinoma of the brain. Neurology. 2012;78(2):e8–10.

    Article  PubMed  Google Scholar 

  20. Fernandez-Miranda JC, Gardner PA, Snyderman CH, Devaney KO, Mendenhall WM, Suárez C, et al. Clival chordomas: a pathological, surgical, and radiotherapeutic review. Head Neck. 2014;36(6):892–906.

    Article  PubMed  Google Scholar 

  21. Nakadate M, Yoshida K, Ishii A, Koizumi M, Tochigi N, Suzuki Y, et al. Is 18F-FDG PET/CT useful for distinguishing between primary thyroid lymphoma and chronic thyroiditis? Clin Nucl Med. 2013;38(9):709–14.

    Article  PubMed  Google Scholar 

  22. Murad V, Kim EE. 18F-FDG PET/CT evaluation of thymomas: a pictorial review. Nucl Med Mol Imaging. 2021; https://doi.org/10.1007/s13139-021-00705-7.

  23. Chong S, Kim TS, Kim B-T, Cho EY, Kim J. Pulmonary artery sarcoma mimicking pulmonary thromboembolism: integrated FDG PET/CT. AJR. 2007;188:1691–3.

    Article  PubMed  Google Scholar 

  24. Pfau D, Smith DA, Beck R, Gilani KA, Gupta A, Caimi P, et al. Primary mediastinal large B-cell lymphoma: a review for radiologists. AJR. 2019;213(5):194–210.

    Article  Google Scholar 

  25. Rosen EL, Eubank WB, Mankoff DA. FDG PET, PET/CT, and breast cancer imaging 1. RadioGraphics. 2007;27:S215–9.

    Article  PubMed  Google Scholar 

  26. Tateishi U, Hasegawa T, Kusumoto M, Yamazaki N, Linuma G, Muramatsu Y, et al. Metastatic angiosarcoma of the lung: spectrum of CT findings. AJR. 2003;180:1671–4.

    Article  PubMed  Google Scholar 

  27. Deng S, Sun X, Zhu Z, et al. Primary malignant melanoma of the lung: a case report and literature review. BMC Pulm Med. 2020;20:94.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Angirish B, Sanghavi P, Jankharia B. Pulmonary manifestations of lymphoma: a pictorial essay. Lung India. 2020;37(3):263–7.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Costa L, Queiroz M, Barbosa F, Nunes RF, Zaniboni EC, Mazo M, et al. Reassessing patterns of response to immunotherapy with PET: from morphology to metabolism. RadioGraphics. 2020;41(1):120–43.

    Article  PubMed  Google Scholar 

  30. Schwarz C, Lübbert H, Rahn W, Schönfeld N, Serke M, Loddenkemper R. Medical thoracoscopy: hormone receptor content in pleural metastases due to breast cancer. Eur Respir J. 2004;24:728–30.

    Article  CAS  PubMed  Google Scholar 

  31. Ko SM, Kim TH, Chun EJ, Kim JY, Hwang SH. Assessment of left ventricular myocardial diseases with cardiac computed tomography. Korean J Radiol. 2019;20(3):333–51.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ulaner G, Lyall A. Identifying and distinguishing treatment effects and complications from malignancy at FDG PET/CT. RadioGraphics. 2013;33(6):1817–34.

    Article  PubMed  Google Scholar 

  33. Gaspar RC, Pauli JR, Shulman GI, Muñoz VR. An update on brown adipose tissue biology: a discussion of recent findings. Am J Physiol Endocrinol Metab. 2021;320(3):488–95.

    Article  Google Scholar 

  34. Wagner T, Brechemier D, Duget E, Le Guellec SL, Julian A, Hitzel A, Beyne O. Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs. Cancer Imaging. 2012;12(1):7–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Parihar A, Kumar R, Singh H, Mittal B. 18F-FDG PET/CT in Takayasu arteritis – active or inactive? J Nucl Med. 2020;61(supplement 1):643.

    Google Scholar 

  36. Lewis RB, Mehrotra AK, Rodriguez P, Levine MS. From the radiologic pathology archives: esophageal neoplasms: radiologic-pathologic correlation. RadioGraphics. 2013;33(4):1083–108.

    Article  PubMed  Google Scholar 

  37. Phongkitkarun S, Varavithya V, Kazama T, Faria SC, Mar MV, Podoloff DA, et al Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose. World J Gastroenterol 2005;11(46):7284–7289.

    Google Scholar 

  38. Bărbulescu M, Alecu L, Boeţi P, Popescu I. Port-site metastasis after laparoscopic surgery for colorectal cancer--still a real concern? Case report and review of the literature. Chirurgia (Bucur). 2012;107(1):103–7. PMID: 22480124.

    Google Scholar 

  39. Lu RC, She B, Gao WT, Ji YH, Xu DD, Wang QS, et al. Positron-emission tomography for hepatocellular carcinoma: current status and future prospects. World J Gastroenterol. 2019;25(32):4682–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Sureshbabu W, Mawlawi O. PET/CT imaging artifacts. J Nucl Med Technol. 2005;33(3):156–61.

    PubMed  Google Scholar 

  41. Martínez-de-Alegría A, Baleato-González S, García-Figueiras R, Bermúdez-Naveira A, Abdulkader-Nallib I, Díaz-Peromingo JA. IgG4-related disease from head to toe. RadioGraphics. 2015;35(7):2007–25.

    Article  PubMed  Google Scholar 

  42. Chang MC, Chen JH, Liang JA, Huang WS, Cheng KY, Kao CH. PET or PET/CT for detection of peritoneal carcinomatosis: a meta-analysis. Clin Nucl Med. 2013;38(8):623–9.

    Article  PubMed  Google Scholar 

  43. Recht H, Solnes L, Merrill S, Siegelman S. 18-FDG PET/CT findings in hemophagocytic lymphohistiocytosis: a pictorial review. J Nucl Med. 2020;61(supplement 1):1140.

    Google Scholar 

  44. Dickson PV, Sims TL, Streck CJ, et al. Avoiding misdiagnosing neuroblastoma as Wilms tumor. J Pediatr Surg. 2008;43(6):1159–63.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Wang HY, Ding HJ, Chen JH, et al. Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma. Cancer Imaging. 2012;12:464–74.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Almodovar S, Israel D, Sakellis C. PET/CT findings of renal lymphoma. J Nuc Med. 2008;49(supplement 1):175.

    Google Scholar 

  47. Zattoni F, Incerti E, Dal Moro F, Moschini M, Castellucci P, Panareo S. 18F-FDG PET/CT and urothelial carcinoma: impact on management and prognosis-a multicenter retrospective study. Cancers. 2019;11(5):700.

    Article  CAS  PubMed Central  Google Scholar 

  48. Shen G, Liu J, Hao Z, Huang R, Kuang A. Is 18F-FDG PET/CT a useful tool in prostate cancer? J Nucl Med. 2017;58(supplement 1):1077.

    Google Scholar 

  49. Lian L, Wang C, Tian JL. IgG4-related retroperitoneal fibrosis: a newly characterized disease. Int J Rheum Dis. 2016;19(11):1049–55.

    Article  CAS  PubMed  Google Scholar 

  50. Nowakowski GS, Czuczman MS. ABC, GCB, and double-hit diffuse large B-cell lymphoma: does subtype make a difference in therapy selection? Am Soc Clin Oncol Educ Book. 2015:e449–57. https://doi.org/10.14694/EdBook_AM.2015.35.e449.

  51. Phin EY, Anthony M-P, Yu-Hung A, Loong F, Khong P-L. Utility of FDG PET/CT in the assessment of myeloid sarcoma. AJR. 2012;198:1175–9.

    Article  Google Scholar 

  52. Murad V, Kim EE. Uterine endometrial stromal sarcoma on MRI and 18F-FDG PET/CT: a case report with literature review. J Med Imaging Case Rep. 2021;5(1):3–5.

    Article  Google Scholar 

  53. Narayanan P, Sahdev A. The role of 18F-FDG PET CT in common gynaecological malignancies. Br J Radiol. 2017;90:1079.

    Article  Google Scholar 

  54. Pectasides D, Pectasides E, Economopoulos T. Fallopian tube carcinoma: a review. Oncologist. 2006;11(8):902–12.

    Article  PubMed  Google Scholar 

  55. Nakatani K, Nakamoto Y, Togashi K. Unilateral physiological FDG uptake in teres minor muscle seems well associated with IV tracer injection procedures. Clin Nucl Med. 2015;40(1):62–4.

    Article  PubMed  Google Scholar 

  56. Lin N, Song Y, Zheng W, Tu M, Xie Y, Wang X, et al. Non-upper aerodigestive tract NK/T- cell lymphoma: an analysis of clinical features and survival from a single center in China. Zhonghua Xue Ye Xue Za Zhi. 2015;36(1):29–33.

    CAS  PubMed  Google Scholar 

  57. Lin M, Kilanowska J, Taper J, Chu J. Neurolymphomatosis—diagnosis and assessment of treatment response by FDG PET-CT. Hematol Oncol. 2008;26:43–5.

    Article  CAS  PubMed  Google Scholar 

  58. Liu F, Zhang Q, Zhou D, Dong J. Effectiveness of 18F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies. BMC Cancer. 2019;19(1):323.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Gengler C, Guillou L. Solitary fibrous tumor and hemangiopericytoma: evolution of a concept. Histopathology. 2006;48(1):63–74.

    Article  CAS  PubMed  Google Scholar 

  60. Lee K, Kim KW, Ko Y, Park HY, Chae EJ, Lee JH, et al. Comprehensive updates in the role of imaging for multiple myeloma management based on recent international guidelines. Korean J Radiol. 2021;22:80.

    Article  Google Scholar 

  61. Kivrak AS, Koc O, Emlik D, Kiresi D. Differential diagnosis of dumbbell lesions associated with spinal neural foraminal widening: imaging features. Eur J Radiol. 2008;71(1):29–41.

    Article  PubMed  Google Scholar 

  62. Sambri A, Bianchi G, Longhi A, Righi A, Donati DM, Nanni C, et al. The role of 18F-FDG PET/CT in soft tissue sarcoma. Nucl Med Commun. 2019;40(6):626–31.

    Article  CAS  PubMed  Google Scholar 

  63. O’Regan K, Hall M, Jagannathan J, Giardino A, Kelly P, Butrynski J, et al. Imaging of radiation- associated sarcoma. AJR. 2011;197:30–6.

    Article  Google Scholar 

  64. Han EJ, Jang YS, Lee IS, Lee JM, Kang S, Kim HS. Muscular sarcoidosis detected by F-18 FDG PET/CT in a hypercalcemic patient. J Korean Med Sci. 2013;28(9):1399–402.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Rais-Bahrami S, Efstathiou JA, Turnbull CM, et al. 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review. Prostate Cancer Prostatic Dis. 2021; https://doi.org/10.1038/s41391-021-00382-9.

  66. Junaid M, Sun M, Skafida M, Obaid M, Ivanidze J, Osborne J, et al. Review of commonly used prostate specific PET tracers used in prostate cancer imaging in current clinical practice. Clin Imaging. 2021;79:278–88.

    Article  Google Scholar 

  67. Tirosh A, Kebebew E. The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors. Future Oncol. 2018;14(2):111–22.

    Article  CAS  PubMed  Google Scholar 

  68. Unterrainer M, Ruf V, Ilhan H, Vettermann FJ, Cyran CC, Niyazi M, et al. 68Ga-DOTATOC PET/CT differentiates meningioma from dural metastases. Clin Nucl Med. 2019;44(5):412–3.

    Article  PubMed  Google Scholar 

  69. Suh M, Im HJ, Ryoo HG, Kang KW, Jeong JM, Prakash S, Ballal SS, Yadav MP, Bal C, Jeong CW, Kwak C, Cheon GJ. Head to head comparison of 68Ga-NGUL and 68Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study. J Nucl Med. 2021; https://doi.org/10.2967/jnumed.120.258434.

  70. Giammarile F, Castellucci P, Dierckx R, et al. Non-FDG PET/CT in diagnostic oncology: a pictorial review. Eur J Hybrid Imaging. 2019;3(20):3–20.

    Google Scholar 

  71. Cohen AD, Klunk WE. Early detection of Alzheimer’s disease using PiB and FDG PET. Neurobiol Dis. 2014;72, Part A(0):117–22.

    Article  Google Scholar 

  72. Oh M, Lee N, Kim C, et al. Diagnostic accuracy of dual-phase 18F-FP-CIT PET imaging for detection and differential diagnosis of Parkinsonism. Sci Rep. 2021;11:14992.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Beer AJ, Haubner R, Sarbia M, Goebel M, Luderschmidt S, Grosu AL, et al. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man. Clin Cancer Res. 2006;12:3942–9.

    Article  CAS  PubMed  Google Scholar 

  74. Farolfi A, Calderoni L, Mattana F, Mei R, Telo S, Fanti S, et al. Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer. J Nucl Med. 2021;62(5):596–604.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

    Vanessa Murad, Jin-Chul Paeng & Gi-Jeong Cheon

  2. Department of Diagnostic Imaging, Fundacion Santa Fe de Bogotá University Hospital, Bogota, Colombia

    Vanessa Murad

  3. Department of Radiological Sciences, University of California, Irvine, School of Medicine, Orange, CA, USA

    E. Edmund Kim

  4. Department of Nuclear Medicine and Department of Molecular Medicine, Graduate School of Convergence Science and Technology, Seoul National University College of Medicine, Seoul, Republic of Korea

    E. Edmund Kim

  5. Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada

    Camilo Barragan

Authors
  1. Vanessa Murad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Edmund Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jin-Chul Paeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Camilo Barragan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gi-Jeong Cheon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiological Sciences, University of California, Irvine, School of Medicine, Orange, CA, USA

    E. Edmund Kim

  2. Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea (Republic of)

    Vanessa Murad

  3. Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea (Republic of)

    Jin-Chul Paeng

  4. Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea (Republic of)

    Gi-Jeong Cheon

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Murad, V., Kim, E.E., Paeng, JC., Barragan, C., Cheon, GJ. (2022). Atlas and Anatomy of PET/CT. In: Kim, E.E., Murad, V., Paeng, JC., Cheon, GJ. (eds) Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT. Springer, Cham. https://doi.org/10.1007/978-3-030-92349-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-92349-5_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-92348-8

  • Online ISBN: 978-3-030-92349-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation